Trade Now

Capital at risk Advertisement
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 1,315.80 1,309.40 1,309.60 0.00 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 34,114.0 5,442.0 87.6 15.0 53,518

GSK's Cervarix Two-Dose Vaccine Schedule Approved in China

27/05/2022 7:40am

Dow Jones News

Historical Stock Chart

From Mar 2022 to Sep 2022

Click Here for more Gsk Charts.

By Jaime Llinares Taboada


GSK PLC said Friday that China has approved a two-dose schedule for its Cervarix vaccine for girls aged nine to 14.

The healthcare company said that the vaccine is against certain types of cancer-causing human papillomavirus. In 2020, there were 110,000 new cases of cervical cancer and 59,000 deaths due to the disease in China, it said.

The authorization of the two-dose regime by the Chinese regulator adds to approvals in around 100 countries. The three-dose schedule remains on the label for girls and women aged 15-45 years in China, GSK said.


Write to Jaime Llinares Taboada at; @JaimeLlinaresT


(END) Dow Jones Newswires

May 27, 2022 02:25 ET (06:25 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

1 Year Gsk Chart

1 Year Gsk Chart

1 Month Gsk Chart

1 Month Gsk Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20220930 06:29:52